 |
Bis(4-fluorophenyl)phenylacetamide |
|---|---|
| Trade Name | |
| Orphan Indication | Sickle cell anemia |
| USA Market Approval | USA |
| USA Designation Date | 2000-03-02 00:00:00 |
| Sponsor | ICAgen Inc.;Ion Channel Advances, PO Box 14487;Durham, North Carolina, 27709 |
Related Access Program